NO941519L - 2-amino-4-heteroaryl-1,4-dihydropyridiner, fremgangsmåte for deres fremstilling og deres anvendelse i legemidler - Google Patents
2-amino-4-heteroaryl-1,4-dihydropyridiner, fremgangsmåte for deres fremstilling og deres anvendelse i legemidlerInfo
- Publication number
- NO941519L NO941519L NO941519A NO941519A NO941519L NO 941519 L NO941519 L NO 941519L NO 941519 A NO941519 A NO 941519A NO 941519 A NO941519 A NO 941519A NO 941519 L NO941519 L NO 941519L
- Authority
- NO
- Norway
- Prior art keywords
- carbon atoms
- formula
- heteroaryl
- amino
- optionally substituted
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 abstract 3
- 229910052717 sulfur Inorganic materials 0.000 abstract 2
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000837 carbohydrate group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229920006395 saturated elastomer Polymers 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4313696A DE4313696A1 (de) | 1993-04-27 | 1993-04-27 | 2-Amino-4-heteroaryl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO941519D0 NO941519D0 (en:Method) | 1994-04-26 |
| NO941519L true NO941519L (no) | 1994-10-28 |
Family
ID=6486454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO941519A NO941519L (no) | 1993-04-27 | 1994-04-26 | 2-amino-4-heteroaryl-1,4-dihydropyridiner, fremgangsmåte for deres fremstilling og deres anvendelse i legemidler |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US5434153A (en:Method) |
| EP (1) | EP0622365A1 (en:Method) |
| JP (1) | JPH06321943A (en:Method) |
| CN (1) | CN1100725A (en:Method) |
| AU (1) | AU671001B2 (en:Method) |
| CA (1) | CA2121963A1 (en:Method) |
| CZ (1) | CZ99594A3 (en:Method) |
| DE (1) | DE4313696A1 (en:Method) |
| FI (1) | FI941915A7 (en:Method) |
| HU (1) | HUT70540A (en:Method) |
| IL (1) | IL109439A0 (en:Method) |
| NO (1) | NO941519L (en:Method) |
| NZ (1) | NZ260385A (en:Method) |
| PH (1) | PH30808A (en:Method) |
| RU (2) | RU94014255A (en:Method) |
| SK (1) | SK47994A3 (en:Method) |
| ZA (1) | ZA942884B (en:Method) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004272078A1 (en) * | 2003-09-10 | 2005-03-24 | Synta Pharmaceuticals Corp. | Dihydropyridine compounds for treating or preventing metabolic disorders |
| CA2752603C (en) | 2009-02-18 | 2016-04-05 | Bayer Pharma Aktiengesellschaft | Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3946026A (en) * | 1972-03-06 | 1976-03-23 | Bayer Aktiengesellschaft | 2-Amino-1,4-dihydropyridine derivatives |
| DE2242786A1 (de) * | 1972-08-31 | 1974-03-14 | Bayer Ag | Verfahren zur herstellung von neuen 2-amino-1,4-dihydropyridinen mit einer carbonylfunktion sowie ihre verwendung als arzneimittel |
| US3989708A (en) * | 1972-08-31 | 1976-11-02 | Bayer Aktiengesellschaft | 2-Amino-1,4-dihydropyridine derivatives |
| DE2639257A1 (de) * | 1976-09-01 | 1978-03-02 | Bayer Ag | Aminoalkylidenamino-1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE3311003A1 (de) * | 1983-03-25 | 1984-09-27 | Bayer Ag, 5090 Leverkusen | Chromon- und thiochromonsubstituierte 1,4-dihydropyridinlactone, mehrere verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| DE4011106A1 (de) * | 1990-04-06 | 1991-10-10 | Bayer Ag | Neue heterocyclisch substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| US5254692A (en) * | 1990-04-06 | 1993-10-19 | Bayer Aktiengesellschaft | 2,6-dialkyl-4-(benzothiazol- or benzoxazol-7-yl)-1,4-dihydropyridines |
| DE4117750A1 (de) * | 1991-05-30 | 1992-12-24 | Bayer Ag | Neue 2-amino-5-cyano-1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| DE4134760A1 (de) * | 1991-10-22 | 1993-07-08 | Bayer Ag | Aryl-chinolyl-substituierte 1,4-dihydropyridin-dicarbonsaeurederivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| DE4202526A1 (de) * | 1992-01-30 | 1993-08-05 | Bayer Ag | Neue 4-cinnolinyl- und 4-naphthyridinyl-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
-
1993
- 1993-04-27 DE DE4313696A patent/DE4313696A1/de not_active Withdrawn
-
1994
- 1994-03-31 AU AU59222/94A patent/AU671001B2/en not_active Ceased
- 1994-04-14 EP EP94105777A patent/EP0622365A1/de not_active Withdrawn
- 1994-04-20 US US08/230,468 patent/US5434153A/en not_active Expired - Fee Related
- 1994-04-22 CA CA002121963A patent/CA2121963A1/en not_active Abandoned
- 1994-04-22 NZ NZ260385A patent/NZ260385A/en unknown
- 1994-04-25 PH PH48148A patent/PH30808A/en unknown
- 1994-04-25 FI FI941915A patent/FI941915A7/fi unknown
- 1994-04-26 ZA ZA942884A patent/ZA942884B/xx unknown
- 1994-04-26 HU HU9401191A patent/HUT70540A/hu unknown
- 1994-04-26 RU RU94014255/04A patent/RU94014255A/ru unknown
- 1994-04-26 CZ CZ94995A patent/CZ99594A3/cs unknown
- 1994-04-26 NO NO941519A patent/NO941519L/no unknown
- 1994-04-26 JP JP6109205A patent/JPH06321943A/ja active Pending
- 1994-04-26 SK SK479-94A patent/SK47994A3/sk unknown
- 1994-04-26 IL IL10943994A patent/IL109439A0/xx unknown
- 1994-04-26 RU RU94014627/04A patent/RU94014627A/ru unknown
- 1994-04-27 CN CN94104685A patent/CN1100725A/zh active Pending
-
1995
- 1995-01-23 US US08/377,063 patent/US5478937A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CZ99594A3 (en) | 1994-11-16 |
| FI941915A7 (fi) | 1994-10-28 |
| AU671001B2 (en) | 1996-08-08 |
| DE4313696A1 (de) | 1994-11-03 |
| US5478937A (en) | 1995-12-26 |
| HUT70540A (en) | 1995-10-30 |
| IL109439A0 (en) | 1994-07-31 |
| ZA942884B (en) | 1995-01-04 |
| RU94014255A (ru) | 1997-02-20 |
| HU9401191D0 (en) | 1994-07-28 |
| NZ260385A (en) | 1996-04-26 |
| AU5922294A (en) | 1994-11-03 |
| US5434153A (en) | 1995-07-18 |
| JPH06321943A (ja) | 1994-11-22 |
| RU94014627A (ru) | 1997-02-20 |
| PH30808A (en) | 1997-10-17 |
| SK47994A3 (en) | 1994-12-07 |
| FI941915A0 (fi) | 1994-04-25 |
| EP0622365A1 (de) | 1994-11-02 |
| CN1100725A (zh) | 1995-03-29 |
| CA2121963A1 (en) | 1994-10-28 |
| NO941519D0 (en:Method) | 1994-04-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5130317A (en) | Pyrimidine-4,6-dicarboxylic acid diamides, processes for the use thereof, and pharmaceuticals based on these compounds | |
| NO941770L (no) | Substituert mono- og bipyridylmetylpyridon | |
| KR960011372B1 (ko) | 피리딘-2,4-및-2,5-디카복실산 아미드, 그의 제조방법 및 용도 | |
| KR960701019A (ko) | 신규의 4-아미노피리딘, 이것의 제조방법 및 이것을 함유하는 약제(new 4-aminopyridines, process for preparing the same and me-dicaments containing the same) | |
| AR066036A2 (es) | Derivados de hidroxi-1- azobenceno, composiciones farmaceuticas que los comprenden, uso de dichos compuestos en la fabricacion de medicamentos, proceso para preparar dichas composiciones, proceso para preprar dichos compuestos, metodo in vitro o ex vivo para aumentar la estimulacion de la maduracion | |
| NO975987L (no) | 4-Fenylaminotiazol-derivater, fremgangsmåte for fremstilling av disse og farmasöytiske blandinger inneholdende nevnte derivater | |
| PT84651B (pt) | Processo para a preparacao de indolinas 3,3-dissubstituidas e de composicoes farmaceuticas que as contem | |
| FI95132B (fi) | Menetelmä antianginaalisten 5-(2-alkoksi-5-piperidinyyli- ja -piperatsinyylisulfonyylifenyyli)-1,6-dihydro-7H-pyratsolo/4,3-d/pyrimidin-7-onien valmistamiseksi ja välituotteita | |
| NO20070249L (no) | Pyrrazolo-pyrimidin derivater | |
| DE68908040D1 (de) | 3-(4-piperidin)-5-(2-sulphonylaminoethyl)-indol-derivate. | |
| NO20071658L (no) | Alkil-pyridiner som 11-beta-inhibitorer for diabetes | |
| MX2010008362A (es) | Derivados de heteroarilamida diazepinopirimidona sustituidos. | |
| PT1601653E (pt) | Processo para a produção de ésteres de ácido nicotínico substituído | |
| KR960011371B1 (ko) | 피리딘-2,4-및-2,5-디카복실산 유도체, 이의 제조방법, 이의 용도, 및 이들 화합물을 기본으로 하는 약제 | |
| US3632806A (en) | Novel n - pyridylmethylidene - homo-cysteine thiolactone compound and the preparation thereof | |
| NO941519L (no) | 2-amino-4-heteroaryl-1,4-dihydropyridiner, fremgangsmåte for deres fremstilling og deres anvendelse i legemidler | |
| HUT47531A (en) | Process for producing amide derivatives and pharmaceuticals comprising such compounds | |
| NO941073L (no) | Fenylglycinamid av heterocykliske, substituerte fenyleddiksyrederivater | |
| ATE32462T1 (de) | Triazolopyrimidinderivate, verfahren zu ihrer herstellung und ihre therapeutische anwendung als kardiotonika. | |
| ATE131061T1 (de) | Förderung der osteogenese durch verwendung von vitamin d-derivaten. | |
| IT1204948B (it) | 2-tiometil-sostituite-piridine, metodo per la loro preparazione e composizioni farmaceutiche che le contengono. | |
| FR2479219B1 (en:Method) | ||
| US5240921A (en) | Cyclic pyridine-2,4- and -2,5-dicarboxylic acid diamides, processes for their preparation and their use | |
| Hisano et al. | Reexamination of the reaction of pyridine 1-oxide with phenyl isocyanate. The isolation of 2, 3-dihydropyridine intermediate and the study of the reaction course | |
| US5512586A (en) | Medicaments based on pyridine-2,4- and 2,5-dicarboxylic acid amides |